Results 161 to 170 of about 737,472 (291)

Longitudinal sex differences in cerebrovascular ageing in older adults: results from the brain in motion study. [PDF]

J Physiol
Snow C, Donald AMH, Pelechaty KM, Gibson J, Hill MD, Rawling JM, Holroyd-Leduc J, Nerenberg K, Holodinsky JK, Longman RS, Poulin MJ.   +10 more
europepmc   +1 more source

Diverse Genetic Etiologies of Unilateral Polymicrogyria

Annals of Neurology, EarlyView.
Objective Polymicrogyria (PMG) is one of the most common human malformations of cortical development and is often classified by its radiographic pattern of distribution. Unilateral polymicrogyria (uPMG) is a subtype of PMG affecting a portion or all of one cerebral hemisphere.
Abbe Lai, Jennifer E. Neil, Shyam K. Akula, Dina Amrom, Eva Andermann, Ann Bergin, Roberto Caraballo, Allen Y. Chen, John Gaitanis, Ganeshwaran H. Mochida, Jill M. Gotoff, Giorgi Kuchukhidze, Daphna Marom, Christelle Moufawad ElAchkar, Miriam Regev, Lance H. Rodan, Heather Olson, Bo Zhang, Annapurna Poduri, Diane D. Shao, Christopher A. Walsh, Edward Yang   +21 more
wiley   +1 more source

Changes in Health Care Utilization Patterns and Outcomes for an Acute Cerebrovascular Events Medicare Cohort, 2018-2022. [PDF]

Neuroepidemiology
Laurido-Soto OJ, Waken RJ, Wang F, Orav EJ, Wadhera RK, Figueroa JF, Searles Nielsen S, Babulal GM, Racette BA, Joynt Maddox KE.   +9 more
europepmc   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, Qing‐Wen Wang, James Cheng Chung Wei   +3 more
wiley   +1 more source

G Protein-Coupled Receptors in Cerebrovascular Diseases: Signaling Mechanisms and Therapeutic Opportunities. [PDF]

Int J Mol Sci
Gu Q, Yao J, Sheng J, Liu D.
europepmc   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

Blood pressure variability and cerebrovascular risk in maintenance hemodialysis versus peritoneal dialysis: a comparative study. [PDF]

Ren Fail
Hu T, Yu T, Xu X, Huang Z, Cao Z, Yu G.
europepmc   +1 more source

Clinical presentation, diagnostic findings and long-term survival in large breed dogs with meningoencephalitis of unknown aetiology [PDF]

, 2016
ADAMO, ALVES, BENJAMINI, BENTLEY, CHERUBINI, CHERUBINI, COATES, COOPER, DICKINSON, ESTEY, FALZONE, FLIEGNER, GAROSI, GAROSI, GAROSI, GRANGER, HIGGINBOTHAM, HIGGINS, MUNANA, PARK, PARZEFALL, PFOHL, SCHATZBERG, SNYDER, SPITZBARTH, TALARICO, TIMMANN, WOLFF, ZARFOSS   +28 more
core   +1 more source

Transforming Brain Health With Neurotechnology Convergence (Part II): Intelligent Neurointervention Systems for Neurological Disorders

Brain Health, EarlyView.
ABSTRACT Neurological disorders represent a critical domain within global health, necessitating advanced interventions to address complex pathologies such as tumors, functional disorders, and cerebrovascular diseases. Despite the proven benefits of early intervention, current treatment paradigms face significant challenges: (1) limited precision in ...
Qing Ye, Fei Peng, Chao Pan, Ping Zhang, Xuewei Xie, Zixiao Li, Yingxin Tang, Danyang Chen, Yuanwei Li, Jiawen Wu, Zao Han, Qing Dai, Quansheng Gu, Jizong Zhao, Zhouping Tang   +14 more
wiley   +1 more source

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy". [PDF]

Eur J Neurol
Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A.   +8 more
europepmc   +1 more source